[e-drug] Correction: Comments on the applications for the 2019 update of the WHO Model List of Essential Medicines (EML) including Essential Medicines for Children (EMLc)

e-drug
1

E-DRUG: Correction: Comments on the applications for the 2019 update of the WHO Model List of Essential Medicines (EML) including Essential Medicines for Children
-------------------------------------------------------------------------------------------------

The correct link to the EML 2019 application page is the following:
https://www.who.int/selection_medicines/committees/expert/22/en/

(the one indicated was the one for 2017 update with the link to the 21st Expert Committee meeting)

The correct message is:
E-DRUG: Comments on the applications for the 2019 update of the WHO Model List of Essential Medicines (EML) including Essential Medicines for Children (EMLc)
-----------------------------------------------------------------------------------------------
The 22nd WHO Expert Committee on Selection and Use of Essential Medicines will meet in Geneva, Switzerland from 1 to 5 April 2019 to consider applications seeking inclusion, changes to or removal of medicines on the WHO Model List of Essential Medicines (EML) including Essential Medicines for Children (EMLc).

Applications received for consideration by the Expert Committee are being published on the WHO Essential Medicines webpage at:
https://www.who.int/selection_medicines/committees/expert/22/en/

This process is currently ongoing and is expected to be completed by early February.

The WHO EML Secretariat invites interested stakeholders to submit comments on the applications.
All comments received will be published on the Essential Medicines webpage, and considered by the Expert Committee. The deadline for submission of comments is 1 March 2019.
Written comments should be provided in PDF format and be submitted via email to emlsecretariat@who.int<mailto:emlsecretariat@who.int>

Regards,

Nicola Magrini, MD
Secretary,
Expert Committee on the Selection and Use of Essential Medicines Innovation,
Access and Use (IAU), Department of Essential Medicines and Health Products
WHO Geneva
"MAGRINI, Nicola" <magrinin@who.int<mailto:magrinin@who.int>>

2

E-DRUG: Comments on the applications for the 2019 update of the WHO Model
List of Essential Medicines (EML) including Essential Medicines for
Children (EMLc)
-----------------------------------------------------------------------------------------------
The 22nd WHO Expert Committee on Selection and Use of Essential Medicines
will meet in Geneva, Switzerland from 1 to 5 April 2019 to consider
applications seeking inclusion, changes to or removal of medicines on the
WHO Model List of Essential Medicines (EML) including Essential Medicines
for Children (EMLc).

Applications received for consideration by the Expert Committee are being
published on the WHO Essential Medicines webpage at:
https://www.who.int/selection_medicines/committees/expert/22/en/

This process is currently ongoing and is expected to be completed by early
February.

The WHO EML Secretariat invites interested stakeholders to submit comments
on the applications.
All comments received will be published on the Essential Medicines webpage,
and considered by the Expert Committee. The deadline for submission of
comments is 1 March 2019.
Written comments should be provided in PDF format and be submitted via
email to emlsecretariat@who.int<mailto:emlsecretariat@who.int>

Regards,

Nicola Magrini, MD
Secretary,
Expert Committee on the Selection and Use of Essential Medicines Innovation,
Access and Use (IAU), Department of Essential Medicines and Health Products
WHO Geneva
"MAGRINI, Nicola" <magrinin@who.int<mailto:magrinin@who.int>>